Meredith S Irwin (Meredith Irwin, Craig Erker)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 26

Top Topics

Chronic Lymphocytic Leukemia

Histone Deacetylase

Platelet Rich Plasma

Stem Cell Transplantation

Top Venues

Pediatric blood & cancer

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Molecular cancer research : MCR

This page only lists publications with an associated author ORCID identifier.

Publications

Puja J Umaretiya, Arlene Naranjo, Fan F Zhang, Meredith S Irwin, Steven G DuBois, Rochelle Bagatell, Kira O Bona
Enrollment on upfront high-risk neuroblastoma trials by race, ethnicity, and poverty status: A report from the Children's Oncology Group. Pediatric blood & cancer (2024)
Puja J Umaretiya, Arlene Naranjo, Fan F Zhang, Meredith S Irwin, Steven G DuBois, Rochelle Bagatell, Kira O Bona
Enrollment on upfront high-risk neuroblastoma trials by race, ethnicity, and poverty status: A report from the Children's Oncology Group. Pediatric blood & cancer 71 (7) (2024)
Puja J Umaretiya, Arlene Naranjo, Fan F Zhang, Meredith S Irwin, Steven G DuBois, Rochelle Bagatell, Kira O Bona
Enrollment on upfront high-risk neuroblastoma trials by race, ethnicity, and poverty status: A report from the Children's Oncology Group. Pediatric blood & cancer 71 (7) (2024)
Puja J Umaretiya, Arlene Naranjo, Fan F Zhang, Meredith S Irwin, Steven G DuBois, Rochelle Bagatell, Kira O Bona
Enrollment on upfront high-risk neuroblastoma trials by race, ethnicity, and poverty status: A report from the Children's Oncology Group. Pediatric blood & cancer 71 (7) (2024)
Hannah G Bender, Meredith S Irwin, Michael D Hogarty, Robert Castleberry, John M Maris, Pei-Chi Kao, Fan F Zhang, Arlene Naranjo, Susan L Cohn, Wendy B London
Survival of Patients With Neuroblastoma After Assignment to Reduced Therapy Because of the 12- to 18-Month Change in Age Cutoff in Children's Oncology Group Risk Stratification. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Hannah G Bender, Meredith S Irwin, Michael D Hogarty, Robert Castleberry, John M Maris, Pei-Chi Kao, Fan F Zhang, Arlene Naranjo, Susan L Cohn, Wendy B London
Survival of Patients With Neuroblastoma After Assignment to Reduced Therapy Because of the 12- to 18-Month Change in Age Cutoff in Children's Oncology Group Risk Stratification. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Ivette Valencia-Sama, Lynn Kee, Gabriella Christopher, Michael Ohh, Mehdi Layeghifard, Adam Shlien, Madeline N Hayes, Meredith S Irwin
SHP2 inhibition with TNO155 increases efficacy and overcomes resistance of ALK inhibitors in neuroblastoma. Cancer research communications (2023)
Rochelle Bagatell, Steven G DuBois, Arlene Naranjo, Jen Belle, Kelly C Goldsmith, Julie R Park, Meredith S Irwin, null null
Children's Oncology Group's 2023 blueprint for research: Neuroblastoma. Pediatric blood & cancer (2023)
Natashia M Seemann, Meredith S Irwin, Meredith S Irwin, Steven R Lopushinsky, Ketan Kulkarni, Conrad V Fernandez, Rodrigo L P Romao
Survival effect of complete surgical resection of the primary tumor in patients with metastatic, high-risk neuroblastoma in a large Canadian cohort. Pediatric blood & cancer (2023)
Navin R Pinto, Arlene Naranjo, Xiangming Ding, Fan F Zhang, Emily Hibbitts, Rebekah Kennedy, Rachelle Tibbetts, Shannon Wong-Michalak, David W Craig, Zarko Manojlovic, Michael D Hogarty, Susan Kreissman, Rochelle Bagatell, Meredith S Irwin, Julie R Park, Shahab Asgharzadeh
Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology without MYCN Amplification. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Navin R Pinto, Arlene Naranjo, Xiangming Ding, Fan F Zhang, Emily Hibbitts, Rebekah Kennedy, Rachelle Tibbetts, Shannon Wong-Michalak, David W Craig, Zarko Manojlovic, Michael D Hogarty, Susan Kreissman, Rochelle Bagatell, Meredith S Irwin, Julie R Park, Shahab Asgharzadeh
Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology without MYCN Amplification. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Navin R Pinto, Arlene Naranjo, Xiangming Ding, Fan F Zhang, Emily Hibbitts, Rebekah Kennedy, Rachelle Tibbetts, Shannon Wong-Michalak, David W Craig, Zarko Manojlovic, Michael D Hogarty, Susan Kreissman, Rochelle Bagatell, Meredith S Irwin, Julie R Park, Shahab Asgharzadeh
Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology without MYCN Amplification. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Yagnesh Ladumor, Bo Kyung Alex Seong, Robin Hallett, Ivette Valencia-Sama, Teresa Adderley, Yingying Wang, Lynn Kee, Alexander Gont, David R Kaplan, Meredith S Irwin
Vitamin D Receptor Activation Attenuates Hippo Pathway Effectors and Cell Survival in Metastatic Neuroblastoma. Molecular cancer research : MCR 20 (6) (2022)
Nida Usmani, Rebecca J Deyell, Carol Portwine, Margarida Simao Rafael, Paul C Moorehead, Amer Shammas, Georg Gruber, Mateo Farfan, Thuvaraha Vanniyasingam, Daniel A Morgenstern, Meredith S Irwin
Residual meta-iodobenzyl guanidine (MIBG) positivity following therapy for metastatic neuroblastoma: Patient characteristics, imaging, and outcome. Pediatric blood & cancer 68 (12) (2021)
Meredith S Irwin, Arlene Naranjo, Fan F Zhang, Susan L Cohn, Wendy B London, Julie M Gastier-Foster, Nilsa C Ramirez, Ruthann Pfau, Shalini Reshmi, Elizabeth Wagner, Jed Nuchtern, Shahab Asgharzadeh, Hiroyuki Shimada, John M Maris, Rochelle Bagatell, Julie R Park, Michael D Hogarty
Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (29) (2021)
Wayne H Liang, Sara M Federico, Wendy B London, Arlene Naranjo, Meredith S Irwin, Samuel L Volchenboum, Susan L Cohn
Tailoring Therapy for Children With Neuroblastoma on the Basis of Risk Group Classification: Past, Present, and Future. JCO clinical cancer informatics 4 (2021)
Melissa Harvey, Meredith S Irwin, Linlea Armstrong, Kim Seath, Sean Young, Sharon Gershony, Rebecca J Deyell
Crizotinib response in a neuroblastoma patient with a constitutional mosaic anaplastic lymphoma kinase I1170N-activating mutation. Pediatric blood & cancer 68 (6) (2021)
Steven G DuBois, Meaghan P Granger, Susan Groshen, Denice Tsao-Wei, Lingyun Ji, Anasheh Shamirian, Scarlett Czarnecki, Fariba Goodarzian, Rachel Berkovich, Hiroyuki Shimada, Judith G Villablanca, Kieuhoa T Vo, Navin R Pinto, Yael P Mosse, John M Maris, Suzanne Shusterman, Susan L Cohn, Kelly C Goldsmith, Brian D Weiss, Gregory A Yanik, Clare J Twist, Meredith S Irwin, Daphne A Haas-Kogan, Julie R Park, Araz Marachelian, Katherine K Matthay
Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (31) (2021)
Lucas Moreno, Dongjing Guo, Meredith S Irwin, Frank Berthold, Michael D Hogarty, Takehiko Kamijo, Daniel A Morgenstern, Claudia Pasqualini, Shifra Ash, Ulrike Potschger, Ruth Ladenstein, Dominique Valteau-Couanet, Susan L Cohn, Andrew D J Pearson, Wendy B London
A nomogram of clinical and biologic factors to predict survival in children newly diagnosed with high-risk neuroblastoma: An International Neuroblastoma Risk Group project. Pediatric blood & cancer 68 (3) (2020)
Frank Milton Balis, Christine Maria Busch, Ami Vijay Desai, Emily Hibbitts, Arlene Naranjo, Rochelle Bagatell, Meredith S Irwin, Elizabeth Fox
The ganglioside GD2 as a circulating tumor biomarker for neuroblastoma. Pediatric blood & cancer 67 (1) (2019)
Colin Wilbur, Carmen Yea, Christoph Licht, Meredith S Irwin, E Ann Yeh
An upfront immunomodulatory therapy protocol for pediatric opsoclonus-myoclonus syndrome. Pediatric blood & cancer 66 (8) (2019)
Natasha Alexander, Katie Sullivan, Furqan Shaikh, Meredith S Irwin
Characteristics and management of ganglioneuroma and ganglioneuroblastoma-intermixed in children and adolescents. Pediatric blood & cancer 65 (5) (2018)
Daniel A Morgenstern, Rochelle Bagatell, Susan L Cohn, Michael D Hogarty, John M Maris, Lucas Moreno, Julie R Park, Andrew D Pearson, Gudrun Schleiermacher, Dominique Valteau-Couanet, Wendy B London, Meredith S Irwin
The challenge of defining "ultra-high-risk" neuroblastoma. Pediatric blood & cancer 66 (4) (2018)
Navin R Pinto, Steven G DuBois, Araz Marachelian, Scott J Diede, Agne Taraseviciute, Julia L Glade Bender, Denice Tsao-Wei, Susan G Groshen, Joel M Reid, Daphne A Haas-Kogan, C Patrick Reynolds, Min H Kang, Meredith S Irwin, Margaret E Macy, Judith G Villablanca, Katherine K Matthay, Julie R Park
Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial. Pediatric blood & cancer 65 (7) (2018)
Catherine Goudie, Noelle Cullinan, Anita Villani, Natalie Mathews, Kalene van Engelen, David Malkin, Meredith S Irwin, William D Foulkes
Retrospective evaluation of a decision-support algorithm (MIPOGG) for genetic referrals for children with neuroblastic tumors. Pediatric blood & cancer 65 (12) (2018)
Donna L Johnston, Sean Murray, Meredith S Irwin, John Doyle, Tal Schechter
Autologous stem cell transplantation for refractory opsoclonus myoclonus ataxia syndrome. Pediatric blood & cancer 65 (8) (2018)